Vivozon Pharmaceutical Past Earnings Performance
Past criteria checks 0/6
Vivozon Pharmaceutical's earnings have been declining at an average annual rate of -16.3%, while the Semiconductor industry saw earnings growing at 17.9% annually. Revenues have been growing at an average rate of 9.3% per year.
Key information
-16.3%
Earnings growth rate
-3.3%
EPS growth rate
| Semiconductor Industry Growth | 23.5% |
| Revenue growth rate | 9.3% |
| Return on equity | -2.1% |
| Net Margin | -3.1% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
We Think Vivozon Pharmaceutical (KOSDAQ:082800) Has A Fair Chunk Of Debt
Mar 23
Is Vivozon Healthcare (KOSDAQ:082800) A Risky Investment?
May 06Estimating The Intrinsic Value Of Vivozon Healthcare, Inc. (KOSDAQ:082800)
Feb 18Did You Miss Vivozon Healthcare's (KOSDAQ:082800) Impressive 116% Share Price Gain?
Dec 04Revenue & Expenses BreakdownBeta
How Vivozon Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 71,318 | -2,214 | 22,693 | 2,541 |
| 30 Sep 23 | 71,061 | -27,436 | 37,882 | 3,118 |
| 30 Jun 23 | 66,423 | -29,263 | 37,968 | 2,964 |
| 31 Mar 23 | 59,174 | -33,235 | 38,552 | 2,657 |
| 31 Dec 22 | 51,564 | -26,079 | 27,744 | 1,927 |
| 30 Sep 22 | 52,429 | -65,746 | 27,027 | 1,777 |
| 30 Jun 22 | 52,846 | -72,472 | 29,089 | 1,781 |
| 31 Mar 22 | 57,175 | -69,523 | 31,096 | 3,834 |
| 31 Dec 21 | 57,560 | -69,457 | 31,682 | 3,935 |
| 30 Sep 21 | 56,999 | -47,728 | 28,047 | 5,721 |
| 30 Jun 21 | 51,123 | -41,492 | 21,586 | 5,388 |
| 31 Mar 21 | 48,923 | -39,366 | 16,386 | 3,092 |
| 31 Dec 20 | 43,592 | -43,754 | 10,808 | 2,870 |
| 30 Sep 20 | 40,671 | -30,829 | 4,525 | 363 |
| 31 Dec 19 | 44,953 | -21,631 | 4,931 | 380 |
| 30 Sep 19 | 44,701 | -975 | 8,340 | 400 |
| 30 Jun 19 | 43,254 | -9,392 | 8,583 | 402 |
| 31 Mar 19 | 45,740 | -8,313 | 7,306 | 368 |
| 31 Dec 18 | 46,003 | -8,534 | 7,252 | 360 |
| 30 Sep 13 | 118,417 | -2,229 | 5,125 | 0 |
| 30 Jun 13 | 130,145 | -959 | 5,409 | 0 |
Quality Earnings: A082800 is currently unprofitable.
Growing Profit Margin: A082800 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A082800 is unprofitable, and losses have increased over the past 5 years at a rate of 16.3% per year.
Accelerating Growth: Unable to compare A082800's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A082800 is unprofitable, making it difficult to compare its past year earnings growth to the Semiconductor industry (-31%).
Return on Equity
High ROE: A082800 has a negative Return on Equity (-2.13%), as it is currently unprofitable.